In the area of Health Innovation, several research groups at PSI are engaged in the study of fundamental questions regarding biology and cancer therapy. For example, they explore the structure of proteins – extremely complex biomolecules that are responsible for many different functions in organisms. Using PSI’s large research facilities, scientists also explore processes in biological tissue in order to fully understand their function and the development of specific diseases or deterioration processes. The ultimate goal is to find medicines that allow people to live as healthy a life as possible.
Patients with specific types of cancer are treated at the proton therapy facility on the PSI campus. Radiopharmaceuticals provide cancer treatments for very small tumours distributed throughout the body.
Find out more at: Overview Health Innovation
On 15 August 2023 a patient suffering from oesophageal cancer was treated with proton beam therapy at PSI – for the very first time in Switzerland.
A project that promises to improve the chances of survival for prostate cancer patients has received 2 million Swiss francs in funding.
Synchrotron light can be used in follow-up after a heart transplant to determine whether the body may be rejecting the new organ.
PSI scientists have discovered the very first step occurring in the eye when light hits the retina.
PSI researchers record a molecular film of a cancer drug fitted with a photoswitch. This opens new insights for drug developers.
The PSI scientists Zurab Guguchia and Kirsten Schnorr are to receive grants totalling CHF 3.1 million from the Swiss National Science Foundation for ground-breaking projects.
Newly established Focal Biosciences will focus on bringing together leading experts and scientific discoveries to harness cellular reprogramming in the fight against common age-related diseases.
From research to production – the new pharmaceutical lab at PSI supplies neighbouring hospitals with novel cancer drugs.
Researchers have shown that mirror-image substances – so-called enantiomers – can be better distinguished using helical X-ray light.
Researchers have measured and determined the sources of aerosol pollution at 22 locations in Europe.
Employing high-resolution X-rays to diagnose breast cancer – PSI researchers nominated for the European Inventor Award.
PSI researchers have developed a new substance that disables a vital protein in the cell skeleton.
PSI is involved in the development of a breath test that can be used to diagnose asthma. Imad El Haddad explains why such a test could be extremely useful – especially for children.
The test identifies different virus variants and improves disease prognosis.
The European Research Council approves PSI projects for the development of a quantum computer and brain research worth about 5 million euros.
PSI scientists have shed light on the structure of an important component of the eye: CNG ion channels whose job is to relay optical signals to the brain.
This gallery presents five people who have been treated at the PSI's Center for Proton Therapy.